Prehabilitation Programs Show Promise in Transforming Cardiac Surgery Outcomes

Can Prehabilitation Transform Cardiac Surgery Outcomes?

Prehabilitation programs significantly improve functional capacity and reduce complications in cardiac surgery patients, according to a comprehensive systematic review and meta-analysis of nine randomized controlled trials involving 873 participants. The study, registered with PROSPERO, found that structured exercise interventions prior to surgery led to a mean improvement of 52.4 meters in the six-minute walk test and reduced the incidence of postoperative respiratory complications, particularly atelectasis.

Key Finding: Structured prehabilitation programs before cardiac surgery deliver measurable clinical benefits:
  • 52.4-meter improvement in six-minute walk test performance
  • Reduced respiratory complications, particularly atelectasis
  • 15.2-hour reduction in hospital length of stay
  • Shorter, intensive programs (<4 weeks) with respiratory muscle training showed the strongest results
  • Frailty improvements of approximately 11.6% on Clinical Frailty Scale
This research, analyzing 873 patients across nine randomized controlled trials, represents the most comprehensive evidence to date that prehabilitation should be considered an essential—not optional—component of cardiac surgery preparation.

What Does the Comprehensive Research Tell Us?

The research, conducted across eight countries between 2008 and 2025, represents the most extensive evaluation of prehabilitation in cardiac surgery to date. Previous systematic reviews included fewer patients (665 and 726, respectively) and did not explore the relationship between program components and outcomes with the same level of statistical rigor. The study population primarily consisted of older adults (>65 years) undergoing coronary artery bypass grafting or valve surgery, with approximately 75% being male—highlighting a notable gender disparity in cardiac surgery research. Investigators employed a robust methodological framework, including PRISMA guidelines, Cochrane Risk of Bias assessment, and GRADE evidence evaluation to ensure high-quality analysis. The meta-analysis revealed that prehabilitation was associated with shorter hospital stays (mean difference: -15.2 hours), though impacts on ICU stay duration and mechanical ventilation time did not reach statistical significance. Notably, subgroup analyses indicated that shorter, more intensive programs (<4 weeks) and those incorporating respiratory muscle training showed particularly pronounced benefits, suggesting that program design significantly influences outcomes. Meta-regression analyses revealed clinically meaningful trends, including greater functional improvements with longer program duration and somewhat diminished benefits among older patients, though these relationships did not reach statistical significance due to the limited number of available trials.

One of the study's most important contributions is its examination of frailty and muscle-related parameters as both risk factors and therapeutic targets. Two trials that assessed frailty using the Clinical Frailty Scale demonstrated significant improvements following prehabilitation, with scores decreasing by approximately 11.6% in one study and showing greater improvement compared to controls in another. These findings are particularly relevant given the high prevalence of frailty in cardiac surgery populations and its established association with adverse outcomes. The researchers distinguished between sarcopenia (loss of muscle mass) and dynapenia (loss of strength without evident muscle mass reduction), noting that most studies assessed only grip strength without comprehensive muscle evaluation. "This distinction is crucial for developing targeted interventions," the authors emphasized, "as dynapenia itself is associated with poorer functional capacity and higher complication rates after cardiac surgery." The investigators proposed a structured clinical model for prehabilitation based on their findings, incorporating moderate-intensity aerobic training, progressive resistance exercises, and inspiratory muscle training—all tailored to individual patient characteristics and comorbidities.

Is Cardiac Prehabilitation Reshaping Perioperative Care?

The study's comprehensive approach to prehabilitation represents a significant advance in perioperative cardiac care, positioning structured exercise interventions as a valuable component of surgical preparation rather than merely an optional adjunct. "Prehabilitation should no longer be regarded merely as an optional adjunct but rather as a promising and increasingly relevant component of perioperative care," the authors concluded. Current programs vary considerably in structure and content, with durations ranging from 2-8 weeks and differing combinations of aerobic, resistance, and respiratory training. Only one trial incorporated high-intensity interval training, while most employed moderate continuous training protocols. The limited standardization of approaches underscores the need for more structured interventions that can be consistently applied across clinical settings. Despite these variations, the consistent improvements in functional capacity and reductions in respiratory complications suggest that even relatively brief prehabilitation programs can yield meaningful clinical benefits. The findings align with the growing emphasis on personalized, preventive approaches in perioperative medicine and highlight opportunities for multidisciplinary collaboration between rehabilitation specialists, cardiologists, and cardiac surgeons.

Can Prehabilitation Foster Long-term Health Behaviors?

The systematic review identified significant heterogeneity in how quality of life was assessed across studies, with instruments including SF-36, EQ-5D, QoR-15, HADS, YPAS and DASI. While immediate improvements in these measures were inconsistent, a notable finding was the increased adherence to physical activity among prehabilitation participants, suggesting potential long-term behavioral changes that could yield health benefits beyond the immediate perioperative period. This aspect of prehabilitation may be particularly valuable for cardiovascular patients, for whom sustained physical activity is a cornerstone of secondary prevention.

How Is the Clinical Model Tailored for Safety and Effectiveness?

The researchers' proposed clinical model represents a practical framework synthesized from current evidence rather than a validated protocol. It emphasizes individualization based on patient characteristics, with rehabilitation physicians playing a central role in adapting exercise parameters and progression. The model recommends moderate-intensity aerobic training primarily on cycle ergometers for safety and stability, resistance training targeting major muscle groups with loads at 50-60% of one-repetition maximum, and inspiratory muscle training at 30-50% of baseline maximal inspiratory pressure. This structured approach aims to maximize physiological adaptation while ensuring safety in this high-risk population.

Where Is Cardiac Prehabilitation Headed Next?

Looking ahead, the researchers called for larger multicenter trials with standardized protocols to confirm long-term benefits and cost-effectiveness. They emphasized the importance of incorporating robust measures of frailty, sarcopenia, and patient-reported outcomes in future studies. The integration of prehabilitation into routine cardiac surgical care represents a promising frontier where sports and exercise medicine principles can meaningfully improve surgical outcomes and patient recovery trajectories. This research adds to the growing body of evidence supporting preventive, non-pharmacological interventions in high-risk surgical populations and may ultimately influence clinical practice guidelines for cardiac surgery preparation.

Recommended Clinical Model: Based on the meta-analysis findings, researchers propose a structured prehabilitation approach tailored to individual cardiac surgery patients:
  • Moderate-intensity aerobic training (primarily cycle ergometry for safety)
  • Progressive resistance exercises targeting major muscle groups at 50-60% of one-repetition maximum
  • Inspiratory muscle training at 30-50% of baseline maximal inspiratory pressure
  • Frailty and dynapenia assessment to identify high-risk patients and guide intervention intensity
The distinction between sarcopenia (muscle mass loss) and dynapenia (strength loss) is crucial, as dynapenia independently predicts complications. Future implementation may benefit from digital health technologies to expand access beyond hospital-based programs.

How Do Market Forces Influence the Future of Prehabilitation?

Industry Context: This research emerges amid increasing healthcare system pressure to improve outcomes while reducing length of stay and readmission rates. Prehabilitation represents a relatively low-cost intervention that could significantly impact these metrics in cardiac surgery, which remains among the most resource-intensive procedures in modern medicine. As healthcare systems increasingly adopt value-based care models, interventions that demonstrably improve outcomes while potentially reducing costs are likely to gain traction with both providers and payers. The findings also coincide with growing investment in digital health technologies that could support home-based prehabilitation programs, potentially expanding access beyond traditional hospital-based delivery models.

Summary

A comprehensive systematic review and meta-analysis of nine randomized controlled trials involving 873 cardiac surgery patients demonstrates that structured prehabilitation programs significantly improve preoperative functional capacity and reduce postoperative complications. The research found that exercise interventions before cardiac surgery improved performance on the six-minute walk test by an average of 52.4 meters and reduced respiratory complications, particularly atelectasis, while also shortening hospital stays by approximately 15.2 hours. The study revealed that shorter, more intensive programs lasting less than four weeks and those incorporating respiratory muscle training showed particularly strong benefits. Importantly, the research identified frailty as both a significant risk factor and a therapeutic target, with two trials demonstrating meaningful improvements in Clinical Frailty Scale scores following prehabilitation. The investigators distinguished between sarcopenia and dynapenia, emphasizing that loss of muscle strength without mass reduction is independently associated with poorer outcomes in cardiac surgery patients. Based on these findings, researchers proposed a structured clinical model incorporating moderate-intensity aerobic training, progressive resistance exercises, and inspiratory muscle training, all tailored to individual patient characteristics. The study represents the most extensive evaluation of cardiac prehabilitation to date and positions these interventions as an essential component of perioperative care rather than an optional supplement. The findings align with growing healthcare system pressures to improve surgical outcomes while reducing costs, suggesting that prehabilitation could become a standard element of cardiac surgery preparation as healthcare moves toward value-based care models.

PMCID
12653149